|
ZNF548 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57670000000554E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7235799999904E-05 |
| Normal-vs-Stage2 |
1.555870E-03 |
| Normal-vs-Stage3 |
1.71650000002632E-06 |
| Normal-vs-Stage4 |
7.199300E-03 |
| Stage1-vs-Stage2 |
8.541200E-01 |
| Stage1-vs-Stage3 |
1.434230E-01 |
| Stage1-vs-Stage4 |
2.553600E-01 |
| Stage2-vs-Stage3 |
1.167220E-01 |
| Stage2-vs-Stage4 |
1.706590E-01 |
| Stage3-vs-Stage4 |
8.076800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02069999999388E-05 |
| Normal-vs-AfricanAmerican |
7.67460000000719E-05 |
| Normal-vs-Asian |
1.223670E-04 |
| Caucasian-vs-AfricanAmerican |
5.512400E-01 |
| Caucasian-vs-Asian |
2.429800E-01 |
| AfricanAmerican-vs-Asian |
2.893600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.78690000024662E-07 |
| Normal-vs-Female |
8.095900E-03 |
| Male-vs-Female |
8.143600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.097300E-03 |
| Normal-vs-Extreme_Weight |
1.99341999999048E-05 |
| Normal-vs-Obese |
9.793200E-04 |
| Normal-vs-Extreme_Obese |
3.983300E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.519400E-01 |
| Normal_Weight-vs-Obese |
9.376800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.758600E-01 |
| Extreme_Weight-vs-Obese |
3.301600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.786800E-01 |
| Obese-vs-Extreme_Obese |
3.796600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.347390E-01 |
| Normal-vs-Age(41-60Yrs) |
2.155000E-03 |
| Normal-vs-Age(61-80Yrs) |
9.96819999876664E-08 |
| Normal-vs-Age(81-100Yrs) |
2.980100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.563400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.906600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.148600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.064000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.778000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.225200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.0654999999925E-05 |
| Normal-VS-Type2 PRCC |
8.86930000554287E-08 |
| Normal-VS-KIRP CIMP |
2.565800E-01 |
| Normal-VS-Unclassified PRCC |
2.126400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.558400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.519400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.068200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.794200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.439800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.473600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.750600E-04 |
| Normal-vs-N1 |
8.084300E-02 |
| Normal-vs-N2 |
1.857780E-03 |
| N0-vs-N1 |
6.621400E-01 |
| N0-vs-N2 |
6.011000E-01 |
| N1-vs-N2 |
5.324800E-01 |
|
|
